Optimizing Adaptive Intensive Behavioral Therapy for Obesity During the Transition to Older Adulthood
1 other identifier
interventional
250
1 country
1
Brief Summary
To test adaptive intensive behavioral therapy strategies comprising dietary patterns with varying amounts of protein and including supplemental protein or resistance exercise training for promoting weight loss and attenuating lean mass loss in adults aged 50-75 with obesity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2026
CompletedFirst Posted
Study publicly available on registry
March 3, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2031
August 3, 2026
July 1, 2026
4.8 years
February 25, 2026
July 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Body Weight
Participants will be weighed at baseline through 52 weeks
Baseline, 8 weeks, 16 weeks, 52 weeks
Change in Fat Free Mass
Participants will be scanned via DXA scan to measure overall fat free body mass
Baseline, 8 weeks, 16 weeks, 52 weeks
Secondary Outcomes (11)
Change in Fat Mass
Baseline, 8 weeks, 16 weeks, 52 weeks
Change in Fasting Glucose
Baseline, 8 weeks, 16 weeks, 52 weeks
Change in Fasting Insulin
Baseline, 8 weeks, 16 weeks, 52 weeks
Change in Fasting Hemoglobin A1C
Baseline, 8 weeks, 16 weeks, 52 weeks
Change in Fasting LDL-cholesterol
Baseline, 8 weeks, 16 weeks, 52 weeks
- +6 more secondary outcomes
Study Arms (6)
High Protein Diet Only
ACTIVE COMPARATOREnrollment in State of Slim (SOS) weight loss program with a high protein diet. This arm includes participants identified as responders to the high protein diet counseling in stage 1 at the week 8 assessment.
High Protein Diet + Supplement
ACTIVE COMPARATOREnrollment in State of Slim (SOS) weight loss program with a high protein diet. Participants identified as non-responders at the week 8 assessment will receive protein supplements to augment their intervention plan.
High Protein Diet + Supervised Exercise
ACTIVE COMPARATOREnrollment in State of Slim (SOS) weight loss program with a high protein diet. Participants identified as non-responders at the week 8 assessment will receive supervised resistance training sessions to augment their intervention plan.
Standard Protein Diet Only
ACTIVE COMPARATOREnrollment in State of Slim (SOS) weight loss program with a standard protein diet. This arm includes participants identified as responders to the standard protein diet counseling in stage 1 at the week 8 assessment.
Standard Protein Diet + Supplement
ACTIVE COMPARATOREnrollment in State of Slim (SOS) weight loss program with a standard protein diet. Participants identified as non-responders at the week 8 assessment will receive protein supplements to augment their intervention plan.
Standard Protein Diet + Supervised Exercise
ACTIVE COMPARATOREnrollment in State of Slim (SOS) weight loss program with a standard protein diet. Participants identified as non-responders at the week 8 assessment will receive supervised resistance training sessions to augment their intervention plan.
Interventions
16 week group-based weight loss program with counseling to consume a high protein diet. Approximate macronutrient distributions (carbohydrate:protein:fat) will be 32%:40%:28%.
16 week group-based weight loss program with counseling to consume a standard protein diet. Approximate macronutrient distributions (carbohydrate:protein:fat) will be 53%:20%:27%.
Non-responders from either initial randomized group assigned to this intervention receive twice daily protein supplements.
Non-responders from either initial randomized group assigned to this intervention receive twice weekly small-group supervised resistance exercise training sessions.
Eligibility Criteria
You may qualify if:
- Male or female sex
- all racial and ethnic groups
- BMI: 30-50 kg/m2
- age 50-75 years
- postmenopausal status for ≥1 y if female sex
You may not qualify if:
- \<3 months stable use of other medications affecting body weight or appetite
- \>450 pounds (due to weight limitations of the DXA)
- indication or previous diagnosis of sarcopenia
- existing kidney disease
- current binge eating disorder, anorexia, or bulimia
- untreated hyper- or hypothyroidism, cancer (except basal cell), gastrointestinal disorders affecting food intake or nutrient absorption; any other medical condition, as determined by the study physician, precluding a HP diet and/or daily exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Drew Sayer, MD
University of Alabama at Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 25, 2026
First Posted
March 3, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
June 30, 2031
Study Completion (Estimated)
June 30, 2031
Last Updated
August 3, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- IPD and supporting information will be available at the time of publication of manuscripts associated with this trial.
- Access Criteria
- Freely available for download from PubMed Central as supplemental material to associated manuscripts.
At the time of publication(s) related to this trial, a fully de-identified dataset including individual participant data will be made available so that data analysis can be replicated by other investigators. This dataset will be freely available for download as supplemental material to manuscript(s) submitted to PubMed Central.